Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Sex hormone-binding globulin (SHBG): Identification of the molecular mechanisms that regulate its expression and role in body fat distribution and in the development of type 2 diabetes

IP: David Martinez Selva
Collaborators: Rafael Simó Canonge, Cristina Hernández Pascual
Funding agency: Instituto de Salud Carlos III
Funding: 42000
Reference: CP08/00058
Duration: 01/01/2009 - 31/12/2011

Sex hormone-binding globulin (SHBG): Identification of the molecular mechanisms that regulate its expression and role in body fat distribution and in the development of type 2 diabetes

IP: Rafael Simó Canonge
Collaborators: David Martinez Selva, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 247050
Reference: MS08/00058
Duration: 01/02/2009 - 31/01/2015

Unidad Central de Investigación en Ensayos Clínicos Vall d'Hebron (UCIEC-VH)

IP: Rafael Simó Canonge
Collaborators: Manuel Hernández González, Joan Montaner Villalonga, Mercè Boada Rovira, Ramon Charco Torra, José García Arumí, Albert Pahissa Berga, Josep Sánchez de Toledo Codina, Juan Lorente Guerrero, Miquel Casas Brugué, Monica Anglada Baguena, Miguel Vilardell Tarres, Sara Marsal Barril, Joan Sahuquillo Barris, Cristina Hernández Pascual, Unidad Central de Investigación en Ensayos Clínicos Vall d'Hebron (UCIEC-VH), Unidad Central de Investigación en Ensayos Clínicos Vall d'Hebron (UCIEC-VH)
Funding agency: Instituto de Salud Carlos III
Funding: 781267.51
Reference: CAI08/01/0034
Duration: 01/01/2009 - 31/12/2012

CIBER: Diabetes y Enfermedades Metabólicas

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual, Monica Higuera Urbano
Funding agency: CIBER Diabetes y Enfermedades Metabólicas
Funding: 4200000
Reference: CB07/08/0024
Duration: 01/01/2008 - 01/01/2012

Related news

The study evaluates elecoglipron and shows improvements in glycemic control and body weight compared with placebo.

The study is expected to contribute to the identification of new therapeutic targets and the development of nutritional strategies to improve health.

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.

Related professionals

Ramos Hernandez, Lidia

Ramos Hernandez, Lidia

Administration and Management
Clinical Neuroimmunology
Read more
Moran Rodriguez, Rosa Delia

Moran Rodriguez, Rosa Delia

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Asenjo Gómez, Vanesa

Asenjo Gómez, Vanesa

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Diez Poch, Mónica

Diez Poch, Mónica

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.